actinomycin D: Clinical Trials

14 trials of actinomycin D, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 4 recruiting, 2 active not recruiting, 1 terminated. 14 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 314Completed 6, Recruiting 4, Active not recruiting 2, Terminated 1, Unknown 1

Follow actinomycin D: new trials by email Literature Review of actinomycin D trials Research Report on actinomycin D

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Rhabdomyosarcoma
Phase 3RecruitingChildren's Oncology Group3422026-07-142026-08-25
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Bone Scan, Carboplatin, Computed Tomography - Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor
Phase 3RecruitingChildren's Oncology Group16562025-04-152026-08-25
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Biospecimen Collection, Bone Scan, Computed Tomography - Pleuropulmonary Blastoma
Phase 3RecruitingChildren's Oncology Group1102025-03-212026-08-25
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Biopsy Procedure, Bone Scan, Computed Tomography - Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma
Phase 3RecruitingChildren's Oncology Group2052022-08-042026-08-25
A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma
Phase 3Active not recruitingChildren's Oncology Group1132021-09-142026-07-30
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Cyclophosphamide, Dactinomycin, Irinotecan Hydrochloride - Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma
Phase 3Active not recruitingNational Cancer Institute (NCI)3252016-06-012026-10-01
Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor
Etoposide, actinomycin D, methotrexate - Gestational Trophoblastic Neoplasms
Phase 3UnknownWeiguo Lv2142016-03-012022-06-03
Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia
Dactinomycin, Leucovorin Calcium, Methotrexate - Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor
Phase 3CompletedGOG Foundation572012-06-182022-08-12
Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors
Carboplatin, Cisplatin, Cyclophosphamide - Brain Cancer, Choroid Plexus Tumors
Phase 3TerminatedTufts Medical Center272009-11-012019-08-20
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
Dactinomycin, Doxorubicin Hydrochloride, Radiation Therapy - Adult Kidney Wilms Tumor, Beckwith-Wiedemann Syndrome
Phase 3CompletedChildren's Oncology Group2492009-08-242026-06-03
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
3-Dimensional Conformal Radiation Therapy, Conventional Surgery, Cyclophosphamide - Stage III Kidney Wilms Tumor, Stage IV Kidney Wilms Tumor
Phase 3CompletedChildren's Oncology Group3952007-04-302026-07-24
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Cyclophosphamide, Dactinomycin, Irinotecan Hydrochloride - Adult Rhabdomyosarcoma, Childhood Alveolar Rhabdomyosarcoma
Phase 3CompletedChildren's Oncology Group4812006-12-262023-01-31
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
3-Dimensional Conformal Radiation Therapy, Biospecimen Collection, Chest Radiography - Stage I Kidney Wilms Tumor, Stage II Kidney Wilms Tumor
Phase 3CompletedChildren's Oncology Group8082006-11-062026-06-03
Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
Dactinomycin, Methotrexate - Good Prognosis Metastatic Gestational Trophoblastic Tumor, Hydatidiform Mole
Phase 3CompletedGynecologic Oncology Group2401999-06-012018-05-15

Conditions studied

Rhabdomyosarcoma (4)  ·  Rhabdomyosarcoma, Embryonal (3)  ·  Wilms Tumor (3)  ·  Hydatidiform Mole (2)  ·  Rhabdomyosarcoma, Alveolar (2)  ·  Beckwith-Wiedemann Syndrome (1)  ·  Brain Neoplasms (1)  ·  Choriocarcinoma (1)  ·  Choroid Plexus Neoplasms (1)  ·  Gestational Trophoblastic Disease (1)  ·  Pleuropulmonary blastoma (1)  ·  Sarcoma (1)

Sponsors

Children's Oncology Group (9)  ·  GOG Foundation (1)  ·  Gynecologic Oncology Group (1)  ·  National Cancer Institute (NCI) (1)  ·  Tufts Medical Center (1)  ·  Weiguo Lv (1)

Countries

United States (13)  ·  Canada (11)  ·  Australia (8)  ·  New Zealand (8)  ·  Puerto Rico (6)  ·  Israel (3)  ·  Switzerland (3)  ·  China (1)  ·  Germany (1)  ·  Hungary (1)  ·  Japan (1)  ·  Saudi Arabia (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Elizabeth A Mullen (3)  ·  Abha A Gupta (1)  ·  Christine M Heske (1)  ·  Douglas S Hawkins (1)  ·  Johannes Wolff, MD (1)  ·  Josephine H Haduong (1)  ·  Julian C Schink (1)  ·  Kris Ann P Schultz (1)  ·  Peter F Ehrlich (1)  ·  Raymond Osborne (1)  ·  Wendy Allen-Rhoades (1)

Results publications

PMID 31449468, PMID 38603649, PMID 27811504, PMID 29211618, PMID 29659330, PMID 30091945, PMID 31174239, PMID 32460997, PMID 35072864, PMID 35580298, PMID 37933882, PMID 38936378, PMID 41914453

NIH funding

U10CA180886 (10), U10CA098543 (4), U10CA027469 (2), U10CA180868 (1)